Gene therapy: Small RNAs aid cell transplants

    Article metrics

    With the help of small RNA molecules called microRNAs, a metabolic and neurodegenerative disorder might be treated using gene therapy.

    Patients with Krabbe's disease lack a functioning version of an enzyme called GALC. Transplants of genetically engineered blood stem cells that later develop into white blood cells could potentially deliver a corrected version of GALC. But expressing the protein in the stem cells kills them.

    Alessandra Biffi and Luigi Naldini of the San Raffaele Scientific Institute in Milan, Italy, and their colleagues identified gene-silencing microRNAs that are expressed in the stem cells, but not in the mature white blood cells.The researchers then modified the stem cells so that GALC expression was suppressed by a microRNA in the stem cells but not in the white blood cells. As the cells developed, they were able to deliver GALC to diseased tissues in a mouse model of Krabbe's disease.

    Science Transl. Med. doi:10.1126/scitranslmed.3001522 (2010)

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Gene therapy: Small RNAs aid cell transplants. Nature 468, 479 (2010) doi:10.1038/468479b

    Download citation


    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.